Lihe Su

1.5k total citations
26 papers, 1.1k citations indexed

About

Lihe Su is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lihe Su has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Immunology. Recurrent topics in Lihe Su's work include CAR-T cell therapy research (9 papers), Virus-based gene therapy research (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Lihe Su is often cited by papers focused on CAR-T cell therapy research (9 papers), Virus-based gene therapy research (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Lihe Su collaborates with scholars based in United States, Germany and Switzerland. Lihe Su's co-authors include Linda C. Burkly, Timothy S. Zheng, Beth Browning, Martin Scott, Yen‐Ming Hsu, Ellen A. Garber, Heimo Riedel, Christine Ambrose, Jennifer S. Michaelson and Sarah A. Bixler and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Lihe Su

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihe Su United States 15 577 450 268 150 108 26 1.1k
Julia Jellusova Germany 18 973 1.7× 615 1.4× 133 0.5× 168 1.1× 122 1.1× 28 1.5k
John F. MacMaster United States 11 378 0.7× 411 0.9× 289 1.1× 296 2.0× 83 0.8× 13 993
Tsuyoshi Takahashi Japan 16 340 0.6× 426 0.9× 124 0.5× 421 2.8× 107 1.0× 34 1.1k
Hans‐Juergen Thiesen Germany 18 280 0.5× 551 1.2× 145 0.5× 241 1.6× 59 0.5× 25 1.0k
Sandra J. Saouaf United States 12 986 1.7× 545 1.2× 152 0.6× 227 1.5× 80 0.7× 17 1.4k
Xincheng Zheng United States 16 421 0.7× 392 0.9× 161 0.6× 217 1.4× 32 0.3× 22 883
Jami Willette‐Brown United States 20 914 1.6× 367 0.8× 171 0.6× 228 1.5× 80 0.7× 34 1.3k
Kai Doberstein Germany 19 182 0.3× 524 1.2× 249 0.9× 299 2.0× 46 0.4× 27 1.1k
Anne‐Laure Mathieu France 15 444 0.8× 322 0.7× 62 0.2× 134 0.9× 44 0.4× 39 901
Kimberly A. Solomon United States 16 189 0.3× 358 0.8× 147 0.5× 230 1.5× 74 0.7× 20 880

Countries citing papers authored by Lihe Su

Since Specialization
Citations

This map shows the geographic impact of Lihe Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihe Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihe Su more than expected).

Fields of papers citing papers by Lihe Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihe Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihe Su. The network helps show where Lihe Su may publish in the future.

Co-authorship network of co-authors of Lihe Su

This figure shows the co-authorship network connecting the top 25 collaborators of Lihe Su. A scholar is included among the top collaborators of Lihe Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihe Su. Lihe Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Su, Lihe, Lan Wu, Roy R. Lobb, Paul D. Rennert, & Christine Ambrose. (2022). CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma. OncoImmunology. 11(1). 2111904–2111904. 3 indexed citations
3.
Ambrose, Christine, Lihe Su, Lan Wu, et al.. (2021). Anti-CD19 CAR T cells potently redirected to kill solid tumor cells. PLoS ONE. 16(3). e0247701–e0247701. 13 indexed citations
4.
Rennert, Paul D., Lan Wu, Lihe Su, Roy R. Lobb, & Christine Ambrose. (2021). 160 Evaluation and development of dual and triple antigen targeting CAR-T Engager proteins for Her2-positive CNS metastases and solid tumors. Regular and Young Investigator Award Abstracts. A170–A170. 1 indexed citations
5.
Klesmith, Justin R., Lihe Su, Lan Wu, et al.. (2019). Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins. Molecular Pharmaceutics. 16(8). 3544–3558. 23 indexed citations
6.
Rennert, Paul D., Fay J. Dufort, Lihe Su, et al.. (2018). Abstract 2569: CAR19 T cells secreting antigen-retargeting fusion proteins have remarkable potency against diverse tumor types. Cancer Research. 78(13_Supplement). 2569–2569. 1 indexed citations
7.
Dufort, Fay J., Lihe Su, Lan Wu, et al.. (2018). Activity of CAR19 T cells secreting impact fusion proteins against hematopoietic and solid tumors.. Journal of Clinical Oncology. 36(15_suppl). e15046–e15046. 2 indexed citations
8.
Wu, Fei, Lili Guo, Aniela Jakubowski, et al.. (2013). TNF-Like Weak Inducer of Apoptosis (TWEAK) Promotes Beta Cell Neogenesis from Pancreatic Ductal Epithelium in Adult Mice. PLoS ONE. 8(8). e72132–e72132. 19 indexed citations
9.
Michaelson, Jennifer S., Aldo Amatucci, Rebecca K. Kelly, et al.. (2011). Development of an Fn14 agonistic antibody as an anti-tumor agent. mAbs. 3(4). 362–375. 38 indexed citations
10.
Wen, Dingyi, Sheng Gu, Lihe Su, et al.. (2009). Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells. Journal of Biological Chemistry. 284(47). 32686–32694. 60 indexed citations
11.
Pappu, Bhanu P., Anna Borodovsky, Timothy S. Zheng, et al.. (2008). TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. The Journal of Experimental Medicine. 205(5). 1049–1062. 177 indexed citations
12.
Campbell, Sean, Linda C. Burkly, Joan W. Berman, et al.. (2006). Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells. The Journal of Immunology. 176(3). 1889–1898. 143 indexed citations
13.
Gorelik, Leonid, Anne H. Cutler, Greg Thill, et al.. (2004). Cutting Edge: BAFF Regulates CD21/35 and CD23 Expression Independent of Its B Cell Survival Function. The Journal of Immunology. 172(2). 762–766. 135 indexed citations
14.
Brickelmaier, Margot, Gerard R. Majeau, Zhifang Li, et al.. (2002). Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CD16 Signaling and CD2/CD16-Dependent Apoptosis of CD2+ Cells. The Journal of Immunology. 168(9). 4462–4471. 99 indexed citations
15.
Su, Lihe, Ellen A. Garber, & Yen‐Ming Hsu. (2001). CD154 Variant Lacking Tumor Necrosis Factor Homologous Domain Inhibits Cell Surface Expression of Wild-type Protein. Journal of Biological Chemistry. 276(3). 1673–1676. 3 indexed citations
16.
Garber, Ellen A., et al.. (1999). CD154 Variants Associated with Hyper-IgM Syndrome Can Form Oligomers and Trigger CD40-mediated Signals. Journal of Biological Chemistry. 274(47). 33545–33550. 20 indexed citations
17.
Hsu, Yen‐Ming, et al.. (1997). Heteromultimeric Complexes of CD40 Ligand Are Present on the Cell Surface of Human T Lymphocytes. Journal of Biological Chemistry. 272(2). 911–915. 47 indexed citations
18.
Rotenberg, Susan A., Michael H. Huang, Jian-Wei Zhu, Lihe Su, & Heimo Riedel. (1995). Deletion analysis of protein kinase c inactivation by calphostin C. Molecular Carcinogenesis. 12(1). 42–49. 47 indexed citations
19.
Riedel, Heimo, et al.. (1993). Phorbol ester activation of functional rat protein kinase C β‐1 causes phenotype in yeast. Journal of Cellular Biochemistry. 52(3). 320–329. 19 indexed citations
20.
Su, Lihe, Amadeo M. Parissenti, & Heimo Riedel. (1993). Functional carboxyl terminal deletion map of protein kinase C alpha.. PubMed. 1(1). 1–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Jellusova Breakdown of academic impact, for papers by John F. MacMaster Breakdown of academic impact, for papers by Tsuyoshi Takahashi Breakdown of academic impact, for papers by Hans‐Juergen Thiesen Breakdown of academic impact, for papers by Sandra J. Saouaf Breakdown of academic impact, for papers by Xincheng Zheng Breakdown of academic impact, for papers by Jami Willette‐Brown Breakdown of academic impact, for papers by Kai Doberstein Breakdown of academic impact, for papers by Anne‐Laure Mathieu Breakdown of academic impact, for papers by Kimberly A. Solomon
Rankless by CCL
2026